{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:08:26Z","timestamp":1779152906484,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["K99EB023279"],"award-info":[{"award-number":["K99EB023279"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R21EB022214"],"award-info":[{"award-number":["R21EB022214"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ductal carcinoma in situ (DCIS) will account for 62,930 cases of breast cancer in 2019. DCIS is a pre-invasive lesion which may not progress to invasive carcinoma, yet surgery remains the mainstay treatment. Molecular imaging of a specific marker for DCIS grade for detection and active surveillance are critically needed to reduce potential overtreatment. First, breast cancer marker B7-H3 (CD276) expression was evaluated by immunohistochemical staining in 123 human specimens including benign epithelium (H-score 10.0\u2009\u00b1\u20098.2) and low (20.8\u2009\u00b1\u200917.7), intermediate (87.1\u2009\u00b1\u200969.5), and high (159.1\u2009\u00b1\u200987.6) grade DCIS, showing a positive association with DCIS nuclear grade (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, AUC 0.96). Next, a murine DCIS model was combined with ultrasound molecular imaging of B7-H3 targeted microbubbles to differentiate normal glands from those harboring DCIS (<jats:italic>n<\/jats:italic>\u2009=\u2009100, FVB\/N-Tg(MMTVPyMT)634Mul, AUC 0.89). Finally, photoacoustic and fluorescence molecular imaging with an anti-B7-H3 antibody-indocyanine green conjugate were utilized for DCIS detection (<jats:italic>n<\/jats:italic>\u2009=\u200953). Molecular imaging of B7-H3 expression may allow for active surveillance of DCIS.<\/jats:p>","DOI":"10.1038\/s41523-020-0158-y","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T10:03:17Z","timestamp":1588154597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression"],"prefix":"10.1038","volume":"6","author":[{"given":"Sunitha","family":"Bachawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-8283","authenticated-orcid":false,"given":"Gregory R.","family":"Bean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-9446","authenticated-orcid":false,"given":"Katheryne E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"158_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"158_CR2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fonc.2017.00192","volume":"7","author":"Y Sagara","year":"2017","unstructured":"Sagara, Y., Julia, W., Golshan, M. & Toi, M. Paradigm shift toward reducing overtreatment of ductal carcinoma in situ of breast. Front. Oncol. 7, 192 (2017).","journal-title":"Front. Oncol."},{"key":"158_CR3","doi-asserted-by":"crossref","first-page":"djv372","DOI":"10.1093\/jnci\/djv372","volume":"108","author":"MD Ryser","year":"2016","unstructured":"Ryser, M. D. et al. Outcomes of active surveillance for ductal carcinoma in situ: a computational risk analysis. J. Natl. Cancer Inst. 108, djv372 (2016).","journal-title":"J. Natl. Cancer Inst."},{"key":"158_CR4","first-page":"1","volume":"185","author":"BA Virnig","year":"2009","unstructured":"Virnig, B. A., Shamliyan, T., Tuttle, T. M., Kane, R. L. & Wilt, T. Diagnosis and management of ductal carcinoma in situ (DCIS). Evid. Rep. Technol. Assess 185, 1\u2013549 (2009).","journal-title":"Evid. Rep. Technol. Assess"},{"key":"158_CR5","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis, A. et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur. J. Cancer 51, 2296\u20132303 (2015).","journal-title":"Eur. J. Cancer"},{"key":"158_CR6","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1002\/cncr.30105","volume":"122","author":"OO Shiyanbola","year":"2016","unstructured":"Shiyanbola, O. O. et al. Emerging trends in surgical and adjuvant radiation therapies among women diagnosed with ductal carcinoma in situ. Cancer 122, 2810\u20132818 (2016).","journal-title":"Cancer"},{"key":"158_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-017-4582-0","volume":"168","author":"A Trentham-Dietz","year":"2018","unstructured":"Trentham-Dietz, A. et al. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening. Breast Cancer Res. Treat. 168, 229\u2013239 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"158_CR8","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1001\/jama.299.18.2151","volume":"299","author":"WA Berg","year":"2008","unstructured":"Berg, W. A. et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299, 2151\u20132163 (2008).","journal-title":"JAMA"},{"key":"158_CR9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/radiol.2251011667","volume":"225","author":"TM Kolb","year":"2002","unstructured":"Kolb, T. M., Lichy, J. & Newhouse, J. H. Comparison of the performance of screening mammography, physical examination, and breast us and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225, 165\u2013175 (2002).","journal-title":"Radiology"},{"key":"158_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajog.2014.06.048","volume":"212","author":"JR Scheel","year":"2015","unstructured":"Scheel, J. R., Lee, J. M., Sprague, B. L., Lee, C. I. & Lehman, C. D. Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. Am. J. Obstet. Gynecol. 212, 9\u201317 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"158_CR11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1166\/jnn.2014.9114","volume":"14","author":"Q Wen","year":"2014","unstructured":"Wen, Q. et al. Ultrasound contrast agents and ultrasound molecular imaging. J. Nanosci. Nanotechnol. 14, 190\u2013209 (2014).","journal-title":"J. Nanosci. Nanotechnol."},{"key":"158_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2013.11.013","volume":"72","author":"F Kiessling","year":"2014","unstructured":"Kiessling, F. et al. Recent advances in molecular, multimodal and theranostic ultrasound imaging. Adv. Drug Deliv. Rev. 72, 15\u201327 (2014).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"158_CR13","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1200\/JCO.2016.70.8594","volume":"35","author":"JK Willmann","year":"2017","unstructured":"Willmann, J. K. et al. Ultrasound molecular imaging with BR55 in patients with breast and ovarian lesions: first-in-human results. J. Clin. Oncol. 35, 2133\u20132140 (2017).","journal-title":"J. Clin. Oncol."},{"key":"158_CR14","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/0008-5472.CAN-12-3391","volume":"73","author":"SV Bachawal","year":"2013","unstructured":"Bachawal, S. V. et al. Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res. 73, 1689\u20131698 (2013).","journal-title":"Cancer Res."},{"key":"158_CR15","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1158\/0008-5472.CAN-14-3361","volume":"75","author":"SV Bachawal","year":"2015","unstructured":"Bachawal, S. V. et al. Breast cancer detection by B7-H3 targeted ultrasound molecular imaging. Cancer Res. 75, 2501\u20132509 (2015).","journal-title":"Cancer Res."},{"key":"158_CR16","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.7150\/thno.27221","volume":"8","author":"J Wischhusen","year":"2018","unstructured":"Wischhusen, J. et al. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer. Theranostics 8, 5126\u20135142 (2018).","journal-title":"Theranostics"},{"key":"158_CR17","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s00330-011-2138-y","volume":"21","author":"J Bzyl","year":"2011","unstructured":"Bzyl, J. et al. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur. Radiol. 21, 1988\u20131995 (2011).","journal-title":"Eur. Radiol."},{"key":"158_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/85339","volume":"2","author":"AI Chapoval","year":"2001","unstructured":"Chapoval, A. I. et al. B7-H3: a costimulatory molecule for T cell activation and IFN-\u03b3 production. Nat. Immunol. 2, 269\u2013274 (2001).","journal-title":"Nat. Immunol."},{"key":"158_CR19","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1002\/ijc.28474","volume":"134","author":"L Wang","year":"2014","unstructured":"Wang, L., Kang, F.-B. & Shan, B.-E. B7-H3-mediated tumor immunology: friend or foe? Int. J. Cancer 134, 2764\u20132771 (2014).","journal-title":"Int. J. Cancer"},{"key":"158_CR20","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3892\/or.2014.3405","volume":"32","author":"W Dai","year":"2014","unstructured":"Dai, W., Shen, G., Qiu, J., Zhao, X. & Gao, Q. Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis. Oncol. Rep. 32, 2086\u20132092 (2014).","journal-title":"Oncol. Rep."},{"key":"158_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2011.09.012","volume":"124","author":"A Brunner","year":"2012","unstructured":"Brunner, A., Hinterholzer, S., Riss, P., Heinze, G. & Brustmann, H. Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis. Gynecol. Oncol. 124, 105\u2013111 (2012).","journal-title":"Gynecol. Oncol."},{"key":"158_CR22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/modpathol.2010.95","volume":"23","author":"X Zang","year":"2010","unstructured":"Zang, X. et al. Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Mod. Pathol. 23, 1104\u20131112 (2010).","journal-title":"Mod. Pathol."},{"key":"158_CR23","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/5fa9cfb4-9964-4586-845d-d8205f318d68","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. B7-H3 is overexpressed in patients suffering osteosarcoma and associated with tumor aggressiveness and metastasis. PLoS One 8, e70689 (2013).","journal-title":"PLoS One"},{"key":"158_CR24","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.7150\/thno.18217","volume":"7","author":"KE Wilson","year":"2017","unstructured":"Wilson, K. E. et al. Spectroscopic photoacoustic molecular imaging of breast cancer using a B7-H3-targeted ICG contrast agent. Theranostics 7, 1463\u20131476 (2017).","journal-title":"Theranostics"},{"key":"158_CR25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2013.53.3935","volume":"32","author":"MS Moran","year":"2014","unstructured":"Moran, M. S. et al. Society of surgical oncology\u2013american society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J. Clin. Oncol. 32, 1507\u20131515 (2014).","journal-title":"J. Clin. Oncol."},{"key":"158_CR26","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1158\/1078-0432.CCR-18-0417","volume":"24","author":"KE Wilson","year":"2018","unstructured":"Wilson, K. E., Bachawal, S. V. & Willmann, J. K. Intraoperative resection guidance with photoacoustic and fluorescence molecular imaging using an Anti-B7-H3 antibody-indocyanine green dual contrast agent. Clin. Cancer Res. 24, 3572\u20133582 (2018).","journal-title":"Clin. Cancer Res."},{"key":"158_CR27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1098\/rsfs.2011.0028","volume":"1","author":"P Beard","year":"2011","unstructured":"Beard, P. Biomedical photoacoustic imaging. Interface Focus 1, 602\u2013631 (2011).","journal-title":"Interface Focus"},{"key":"158_CR28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1126\/science.1216210","volume":"335","author":"LV Wang","year":"2012","unstructured":"Wang, L. V. & Hu, S. Photoacoustic tomography: in vivo imaging from organelles to organs. Science 335, 1458\u20131462 (2012).","journal-title":"Science"},{"key":"158_CR29","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1364\/BOE.2.002540","volume":"2","author":"S Kim","year":"2011","unstructured":"Kim, S., Chen, Y.-S., Luke, G. P. & Emelianov, S. Y. In vivo three-dimensional spectroscopic photoacoustic imaging for monitoring nanoparticle delivery. Biomed. Opt. Express 2, 2540\u20132550 (2011).","journal-title":"Biomed. Opt. Express"},{"key":"158_CR30","doi-asserted-by":"publisher","unstructured":"Wang, L. V., Wu, H.-I. & Masters, B. R. Biomedical Optics, Principles and Imaging (Wiley-Interscience, 2008). https:\/\/doi.org\/10.1117\/1.2976007.","DOI":"10.1117\/1.2976007"},{"key":"158_CR31","doi-asserted-by":"crossref","first-page":"101042831881503","DOI":"10.1177\/1010428318815032","volume":"40","author":"G-E Kim","year":"2018","unstructured":"Kim, G.-E., Kim, N. I., Park, M. H. & Lee, J. S. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: association with clinicopathological features and T-cell infiltration. Tumor Biol. 40, 1010428318815032 (2018).","journal-title":"Tumor Biol."},{"key":"158_CR32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3892\/mmr.2012.1158","volume":"7","author":"C Liu","year":"2013","unstructured":"Liu, C. et al. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10. Mol. Med. Rep. 7, 134\u2013138 (2013).","journal-title":"Mol. Med. Rep."},{"key":"158_CR33","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/SLA.0b013e3181f1939d","volume":"252","author":"T Arigami","year":"2010","unstructured":"Arigami, T. et al. B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Ann. Surg. 252, 1044\u20131051 (2010).","journal-title":"Ann. Surg."},{"key":"158_CR34","doi-asserted-by":"crossref","first-page":"683875","DOI":"10.1155\/2010\/683875","volume":"2010","author":"M Loos","year":"2010","unstructured":"Loos, M., Hedderich, D. M., Friess, H. & Kleeff, J. B7-H3 and its role in antitumor immunity. Clin. Dev. Immunol. 2010, 683875 (2010).","journal-title":"Clin. Dev. Immunol."},{"key":"158_CR35","first-page":"66","volume":"6","author":"JR Castellanos","year":"2017","unstructured":"Castellanos, J. R. et al. B7-H3 role in the immune landscape of cancer. Am. J. Clin. Exp. Immunol. 6, 66\u201375 (2017).","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"158_CR36","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-15-2428","volume":"22","author":"E Picarda","year":"2016","unstructured":"Picarda, E., Ohaegbulam, K. C. & Zang, X. Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy. Clin. Cancer Res. 22, 3425\u20133431 (2016).","journal-title":"Clin. Cancer Res."},{"key":"158_CR37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10456-016-9499-4","volume":"19","author":"J Ehling","year":"2016","unstructured":"Ehling, J. et al. In situ validation of VEGFR-2 and \u03b1 v \u00df 3 integrin as targets for breast lesion characterization. Angiogenesis 19, 245\u2013254 (2016).","journal-title":"Angiogenesis"},{"key":"158_CR38","first-page":"1041","volume":"5","author":"LF Brown","year":"1999","unstructured":"Brown, L. F. et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res. 5, 1041\u20131056 (1999).","journal-title":"Clin. Cancer Res."},{"key":"158_CR39","first-page":"1","volume":"13","author":"A Maeda","year":"2014","unstructured":"Maeda, A., Bu, J., Chen, J., Zheng, G. & DaCosta, R. S. Dual in vivo photoacoustic and fluorescence imaging of her2 expression in breast tumors for diagnosis, margin assessment, and surgical guidance. Mol. Imaging 13, 1\u20139 (2014).","journal-title":"Mol. Imaging"},{"key":"158_CR40","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2967\/jnumed.111.092833","volume":"52","author":"AGT Terwisscha van Scheltinga","year":"2011","unstructured":"Terwisscha van Scheltinga, A. G. T. et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J. Nucl. Med. 52, 1778\u20131785 (2011).","journal-title":"J. Nucl. Med."},{"key":"158_CR41","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1158\/1078-0432.CCR-16-2968","volume":"23","author":"E Rosenthal","year":"2017","unstructured":"Rosenthal, E. et al. Sensitivity and specificity of cetuximab-IRDye800CW to identify regional metastatic disease in head and neck cancer. Clin. Cancer Res. 23, 4744\u20134752 (2017).","journal-title":"Clin. Cancer Res."},{"key":"158_CR42","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1158\/1078-0432.CCR-16-3200","volume":"23","author":"G Diot","year":"2017","unstructured":"Diot, G. et al. Multispectral optoacoustic tomography (MSOT) of human breast cancer. Clin. Cancer Res. 23, 6912\u20136922 (2017).","journal-title":"Clin. Cancer Res."},{"key":"158_CR43","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1109\/JSTQE.2009.2034870","volume":"16","author":"D Piras","year":"2010","unstructured":"Piras, D., Xia, W., Steenbergen, W., Van Leeuwen, T. G. & Manohar, S. Photoacoustic imaging of the breast using the twente photoacoustic mammoscope: Present status and future perspectives. IEEE J. Sel. Top. Quantum Electron. 16, 730\u2013739 (2010).","journal-title":"IEEE J. Sel. Top. Quantum Electron."},{"key":"158_CR44","doi-asserted-by":"crossref","first-page":"024007","DOI":"10.1117\/1.3086616","volume":"14","author":"SA Ermilov","year":"2009","unstructured":"Ermilov, S. A. et al. Laser optoacoustic imaging system for detection of breast cancer. J. Biomed. Opt. 14, 024007 (2009).","journal-title":"J. Biomed. Opt."},{"key":"158_CR45","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1118\/1.3497677","volume":"37","author":"RA Kruger","year":"2010","unstructured":"Kruger, R. A., Lam, R. B., Reinecke, D. R., Del Rio, S. P. & Doyle, R. P. Photoacoustic angiography of the breast. Med. Phys. 37, 6096\u20136100 (2010).","journal-title":"Med. Phys."},{"key":"158_CR46","doi-asserted-by":"crossref","first-page":"e1247","DOI":"10.1016\/j.clbc.2018.07.026","volume":"18","author":"Y Goh","year":"2018","unstructured":"Goh, Y. et al. Multispectral optoacoustic tomography in assessment of breast tumor margins during breast-conserving surgery: a first-in-human case study. Clin. Breast Cancer 18, e1247\u2013e1250 (2018).","journal-title":"Clin. Breast Cancer"},{"key":"158_CR47","first-page":"3545","volume":"50","author":"RA McClelland","year":"1990","unstructured":"McClelland, R. A. et al. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res. 50, 3545\u20133550 (1990).","journal-title":"Cancer Res."},{"key":"158_CR48","first-page":"954","volume":"12","author":"CT Guy","year":"1992","unstructured":"Guy, C. T., Cardiff, R. D. & Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954\u2013961 (1992).","journal-title":"Mol. Cell. Biol."},{"key":"158_CR49","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/sj.onc.1203277","volume":"19","author":"RD Cardiff","year":"2000","unstructured":"Cardiff, R. D. et al. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19, 968\u2013988 (2000).","journal-title":"Oncogene"},{"key":"158_CR50","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2013.06.011","volume":"145","author":"K Foygel","year":"2013","unstructured":"Foygel, K. et al. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology 145, 885\u2013894 (2013).","journal-title":"Gastroenterology"},{"key":"158_CR51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1148\/radiol.2491072050","volume":"249","author":"JK Willmann","year":"2008","unstructured":"Willmann, J. K. et al. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology 249, 212\u2013219 (2008).","journal-title":"Radiology"},{"key":"158_CR52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7150\/thno.5341","volume":"3","author":"JE Streeter","year":"2013","unstructured":"Streeter, J. E. & Dayton, P. A. An in vivo evaluation of the effect of repeated administration and clearance of targeted contrast agents on molecular imaging signal enhancement. Theranostics 3, 93\u201398 (2013).","journal-title":"Theranostics"},{"key":"158_CR53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jso.21943","volume":"104","author":"BE Schaafsma","year":"2011","unstructured":"Schaafsma, B. E. et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J. Surg. Oncol. 104, 323\u2013332 (2011).","journal-title":"J. Surg. Oncol."},{"key":"158_CR54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/RLI.0b013e3181c5927c","volume":"45","author":"S Pochon","year":"2010","unstructured":"Pochon, S. et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest. Radiol. 45, 89\u201395 (2010).","journal-title":"Invest. Radiol."},{"key":"158_CR55","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.7150\/thno.9922","volume":"4","author":"KE Wilson","year":"2014","unstructured":"Wilson, K. E., Bachawal, S. V., Tian, L. & Willmann, J. K. Multiparametric spectroscopic photoacoustic imaging of breast cancer development in a transgenic mouse model. Theranostics 4, 1062\u20131071 (2014).","journal-title":"Theranostics"},{"key":"158_CR56","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pacs.2013.08.001","volume":"1","author":"GP Luke","year":"2013","unstructured":"Luke, G. P., Nam, S. Y. & Emelianov, S. Y. Optical wavelength selection for improved spectroscopic photoacoustic imaging. Photoacoustics 1, 36\u201342 (2013).","journal-title":"Photoacoustics"},{"key":"158_CR57","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.11968758","author":"S Bachawal","year":"2020","unstructured":"Bachawal, S., Bean, G. R., Krings, G. & Wilson, K. E. Metadata supporting data files for the published article: evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression. figshare. https:\/\/doi.org\/10.6084\/m9.figshare.11968758 (2020).","journal-title":"figshare."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-020-0158-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-020-0158-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-020-0158-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:47:54Z","timestamp":1670294874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-020-0158-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["158"],"URL":"https:\/\/doi.org\/10.1038\/s41523-020-0158-y","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}